UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 23.

Widmer, D S; Cheng, P F; Eichhoff, O M; Benedetta, C B; Zipser, M C; Schlegel, N C; Javelaud, D; Mauviel, A; Dummer, R; Hoek, K S (2012). Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell & Melanoma Research, 25(3):343-353.

Zipser, M C; Eichhoff, O M; Widmer, D S; Schlegel, N C; Schoenewolf, N L; Stuart, D; Liu, W; Gardner, H; Smith, P D; Nuciforo, P; Dummer, R; Hoek, K S (2011). A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell & Melanoma Research, 24(2):326-333.

Eichhoff, O M; Weeraratna, A; Zipser, M C; Denat, L; Widmer, D S; Xu, M; Kriegl, L; Kirchner, T; Larue, L; Dummer, R; Hoek, K S (2011). Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell & Melanoma Research, 24(4):631-642.

Hoek, K S; Goding, C R (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell & Melanoma Research, 23(6):746-759.

Hoek, K S (2010). Exploring melanoma's massively parallel universe. Pigment Cell & Melanoma Research, 23(3):306-307.

Manga, P; Hoek, K S; Davids, L M; Leachman, S A (2010). From melanocyte to malignant metastatic melanoma. Dermatology Research and Practice, 2010:798324.

Alexaki, V I; Javelaud, D; Van Kempen, L C L; Mohammad, K S; Dennler, S; Luciani, F; Hoek, K S; Juàrez, P; Goydos, J S; Fournier, P J; Sibon, C; Bertolotto, C; Verrecchia, F; Saule, S; Delmas, V; Ballotti, R; Larue, L; Saiag, P; Guise, T A; Mauviel, A (2010). GLI2-mediated melanoma invasion and metastasis. Journal of the National Cancer Institute, 102(15):1148-1159.

Eichhoff, O M; Zipser, M C; Xu, M; Weeraratna, A T; Mihic, D; Dummer, R; Hoek, K S (2010). The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report. Melanoma Research, 20(4):349-355.

Hoek, K S (2010). The new melanoma. Dermatologica Helvetica, 22(3):28-30.

Schlegel, N C; Eichhoff, O M; Hemmi, S; Werner, S; Dummer, R; Hoek, K S (2009). Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells.counters TGF-beta-mediated growth inhibition of melanoma cells. Pigment Cell & Melanoma Research, 22(4):445-453.

Mnich, C D; Hoek, K S; Virkki, L V; Farkas, A; Dudli, C; Laine, E; Urosevic, M; Dummer, R (2009). Green tea extract reduces induction of p53 and apoptosis in UVB-irradiated human skin independent of transcriptional controls. Experimental Dermatology, 18(1):69-77.

Grigoriadis, A; Caballero, O L; Hoek, K S; da Silva, L; Chen, Y T; Shin, S J; Jungbluth, A A; Miller, L D; Clouston, D; Cebon, J; Old, L J; Lakhani, S R; Simpson, A J G; Neville, A M (2009). CT-X antigen expression in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(32):13493-13498.

Fiori, J L; Zhu, T N; O'Connell, M P; Hoek, K S; Indig, F E; Frank, B P; Morris, C; Kole, S; Hasskamp, J; Elias, G; Weeraratna, A T; Bernier, M (2009). Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology, 150(6):2551-2560.

Winklmeier, A; Poser, I; Hoek, K S; Bosserhoff, A K (2009). Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer, 9:52.

Orgaz, J L; Ladhani, O; Hoek, K S; Fernández-Barral, A; Mihic, D; Aguilera, O; Seftor, E A; Bernad, A; Rodríguez-Peralto, J L; Hendrix, M J C; Volpert, O V; Jiménez, B (2009). Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma. Oncogene, 28(47):4147-4161.

Almanzar, G; Olkhanud, P B; Bodogai, M; Dell'agnola, C; Baatar, D; Hewitt, S M; Ghimenton, C; Tummala, M K; Weeraratna, A T; Hoek, K S; Kouprina, N; Larionov, V; Biragyn, A (2009). Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells. Clinical Cancer Research, 15(6):1954-1963.

Hoek, K S; Eichhoff, O M; Widmer, D; Dummer, R (2009). Stemming the flood. Pigment Cell & Melanoma Research, 22(1):6-7.

O'Connell, M P; Fiori, J L; Baugher, K M; Indig, F E; French, A D; Camilli, T C; Frank, B P; Earley, R; Hoek, K S; Hasskamp, J H; Elias, E G; Taub, D D; Bernier, M; Weeraratna, A T (2009). Wnt5A activates the calpain-mediated cleavage of filamin A. Journal of Investigative Dermatology, 129(7):1782-1789.

Hoek, K S; Schlegel, N C; Eichhoff, O M; Widmer, D S; Praetorius, C; Einarsson, S O; Valgeirsdottir, S; Bergsteinsdottir, K; Schepsky, A; Dummer, R; Steingrimsson, E (2008). Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell & Melanoma Research, 21(6):665-676.

Dissanayake, S K; Olkhanud, P B; O'Connell, M P; Carter, A; French, A D; Camilli, T C; Emeche, C D; Hewitt, K J; Rosenthal, D T; Leotlela, P D; Wade, M S; Yang, S W; Brant, L; Nickoloff, B J; Messina, J L; Biragyn, A; Hoek, K S; Taub, D D; Longo, D L; Sondak, V K; Hewitt, S M; Weeraratna, A T (2008). Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Research, 68(24):10205-10214.

Hoek, K S (2008). Genesifter, leading the blind. Pigment Cell & Melanoma Research, 21(5):588-589.

Hoek, K S; Eichhoff, O M; Schlegel, N C; Döbbeling, U; Kobert, N; Schaerer, L; Hemmi, S; Dummer, R (2008). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Research, 68(3):650-656.

Mnich, C D; Hoek, K S; Oberholzer, P A; Seifert, Burkhardt; Hafner, J; Dummer, R; Mihic, D (2007). Reduced pSmad2 immunodetection correlates with increased primary melanoma thickness. Melanoma Research, 17(2):131-136.

This list was generated on Sun Jul 23 22:05:07 2017 CEST.